First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer - Concepedia

Concepedia

Publication | Open Access

First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer

DOI Full Paper Access

74

Citations

27

References

2019

Year

Sung‐Bae Kim, Funda Meric‐Bernstam, Aparna Kalyan, Rong Liu, Takahiko Tanigawa, Anette Sommer, Motonobu Osada, Frank Reetz, Dirk Laurent, Sabine Wittemer‐Rump,

Targeted Oncology

References

	Year	Citations

Page 1